|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | In vitro activities of levofloxacin used alone and in combination with first-and second-line antituberculosis drugs against Mycobacterium tuberculosis 显示文摘 | Rastogi N Goh KS Bryskier A | 1996 | Antimicrob Agents Chemother1996，40，7： | 1 |
| 2 | Relative potential for selection of fluoroquinolone-resistant streptoccus pneumoniae strains by levofloxacin: Comparison with Ciprofloxacin, sparfloxacin and ofloxacin 显示文摘 | Drugeon HB Juvin ME Bryskier | 1999 | J Antimicrob Chemother1999，，： | 1 |
| 3 | Antibacterial activity of roxithromycin:a laboratory evaluation显示文摘 | Bryskier A Gasc JC | 1986 | J Antibiot1986，39，5： | 1 |
| 4 | Classification and structure-activity relationships of fluoroquinolones显示文摘 | Bryskier A Chantot JF | 1995 | Drugs1995，49，： | 1 |
| 5 | In vitro activities of telithromycin ( HMR3647 ) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii,Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensis显示文摘 | Rolain JM Maurin M Bryskier A et al | 2000 | Antimicrob Agents Chemother2000，44，13： | 1 |
| 6 | In vitro evaluation of faropenem activity against anaerobic bacteria显示文摘 | Behra-Miellet J Dabreuil L Bryskier A | 2005 | J Chemother2005，17，： | 1 |
| 7 | New concepts in the field of cephalosporines: C-3' quaternary ammonium cephems (group Ⅳ) 显示文摘 | Bryskier A | 1997 | Clin Microbiol Infect1997，3，1： | 1 |
| 8 | In vitro activities of telithro- myein (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae , Rickettsia typhi, Rickettsia prowasekii , Coxiella burnetii , Bartonella henselae , Bartonella quintana , Bartonella ba- cilli formis , and Ehrlichia cha ffeensis 显示文摘 | Rolain JM Maurin MA Bryskier | 2000 | Antimicrob Agents Che- mother2000，44，： | 1 |
| 9 | Cephems: Fifty years of continuous research review显示文摘 | | 2000 | The Journal of Antibiotics2000，53，10： | 1 |
| 10 | New concepts in the field of cephalosporins:C-3'quaternary ammonium cephems(Group IV)显示文摘 | Bryskier A | 1997 | Clin Microbiol Infect1997，3，1： | 1 |
| 11 | In vitro evaluation of faroponem activity against anaerobic bacteria显示文摘 | Behra-Miellet J Dabreuil L Bryskier A | 2005 | J Chemother2005，17，1： | 1 |
| 12 | Intracellular activities of roxithromycin used alone and in association with other drugs against Mycobacterium avium complex in human macrophages显示文摘 | Rastogi N Labrousse V Bryskier A | 1995 | Antimicrob Agents Chemother1995，39，4： | 1 |
| 13 | Ketolides-telithromycin, an example of a new class of antibacterial agents显示文摘 | Bryskier A | 2000 | Clin Microbiol Infect2000，6，66： | 1 |
| 14 | Novelties in the field of anti-infectives in 1998显示文摘 | Bryskier A | 1999 | Clin Inf Dis1999，29，： | 1 |
| 15 | In vitro evaluation of faropenem activity against anaerobic bacteria 显示文摘 | Behra - Miellet J Dubreuil L Bryskier A | 2005 | J Chemother2005，17，： | 1 |
| 16 | The AcrABTolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli显示文摘 | Chollet R Chevalier J Bryskier A | 2004 | Antimicrob Agents Chemother2004，48，1： | 1 |
| 17 | Penems:new oral β-lactam drugs显示文摘 | BRYSKIER A | 1995 | Expert Opin Investig Drugs1995，4，： | 1 |
| 18 | In vitro activities of levofloxacin used alone and in combination with first and secoud-line antrtuberculous drugs against Mycobacterium tuberculosis显示文摘 | Rastogi N Goh KS Bryskier A | 1996 | Antimicrob Agents Chemother1996，40，： | 1 |
| 19 | In vitro activities of levofloxacin used alone and in combination with first and second-line antituberculous drugs against Mycobacterium tuberculosis显示文摘 | Rastogi N Goh KS Bryskier A | 1996 | Antimicrob Agents Chemother1996，40，： | 1 |
| 20 | In vitro evaluation of faropenem activity against anaerobic bacteria 显示文摘 | Behra-Miellet J Dubreuil L Bryskier A | 2005 | J Chemother2005，17，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员